Insmed to Host Third Quarter 2017 Financial Results Conference Call on Thursday, November 2, 2017
Oct 25, 2017 12:00 pm UTC| Business
BRIDGEWATER, N.J., Oct. 25, 2017 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will release its third quarter...
Brain Corp. Appoints Qualcomm's Matt Grob to its Board of Directors
Oct 25, 2017 12:00 pm UTC| Business
San Diego, Oct. 25, 2017 -- Brain Corp today announced it has appointed Matt Grob to its Board of Directors as a representative of Qualcomm Ventures, the investment arm of Qualcomm Incorporated. Mr. Grob is the...
Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement
Oct 25, 2017 12:00 pm UTC| Business
PARSIPPANY, N.J. and MALVERN, Pa., Oct. 25, 2017 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that it has committed to invest up to $25 million in TELA Bio, a privately-held surgical reconstruction...
FTD Companies, Inc. to Report Third Quarter 2017 Results
Oct 25, 2017 12:00 pm UTC| Business
DOWNERS GROVE, Ill., Oct. 25, 2017 -- FTD Companies, Inc. (Nasdaq:FTD) (the “Company”), a premier floral and gifting company, today announced it will report results for the third quarter ended September 30, 2017 on...
Lakeland Financial Reports Record Performance
Oct 25, 2017 12:00 pm UTC| Business
WARSAW, Ind., Oct. 25, 2017 -- Lakeland Financial Corporation (Nasdaq:LKFN), parent company of Lake City Bank, today reported record third quarter net income of $15.8 million for the three months ended September 30, an...
TPI Composites, Inc. Announces Third Quarter 2017 Earnings Release Date and Conference Call
Oct 25, 2017 12:00 pm UTC| Business
SCOTTSDALE, Ariz., Oct. 25, 2017 -- TPI Composites, Inc. (“TPI”) (Nasdaq:TPIC), a leading global wind blade manufacturer, today announced that the company will release its third quarter 2017 results after the market...
Oct 25, 2017 12:00 pm UTC| Business
SAN CARLOS, Calif., Oct. 25, 2017 -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced...